Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Manuel Cerqueira

Nuclear Medicine Cleveland, OH Medical Doctor

NPI 1356304232 CMS profile 287752

9500 Euclid Ave, Cleveland, OH 44195

Open in the dashboard

General payments

$160,293

140 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Manuel Cerqueira of Cleveland, OH is reported in the CMS Open Payments database as having received $160,293 across 140 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nuclear Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $9,444 10
2021 General $21,511 12
2020 General $37,408 18
2019 General $91,929 100

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Manuel Cerqueira
  • Nuclear Medicine median
  • Middle half of Nuclear Medicine
  • National median

In program year 2025, general payments to Manuel Cerqueira were reported at $0. Among 197 Nuclear Medicine profiles paid that year, the median was $146 and the middle half received between $40 and $372.

Show as a table
Year Manuel Cerqueira Nuclear Medicine median Middle half National median
2019 $91,929 $125 $54–$531 $163
2020 $37,408 $99 $34–$2,125 $114
2021 $21,511 $96 $22–$874 $132
2022 $9,444 $102 $38–$240 $149
2023 $0 $123 $51–$257 $160
2024 $0 $121 $51–$390 $164
2025 $0 $146 $40–$372 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Astellas Pharma US Inc $112,804 108 payments
  2. Ge Healthcare $37,040 6 payments
  3. Pfizer Inc. $8,901 4 payments
  4. Siemens Medical Solutions USA, Inc. $1,182 15 payments
  5. Agfa HealthCare Corporation $223 1 payment
  6. Advanced Accelerator Applications $78 3 payments
  7. Bayer HealthCare Pharmaceuticals Inc. $40 2 payments
  8. Blue Earth Diagnostics Limited $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $127,893 38 payments
  2. Consulting Fee $11,149 1 payment
  3. Travel and Lodging $9,597 49 payments
  4. Honoraria $8,800 3 payments
  5. Food and Beverage $2,853 49 payments
Products named General payments · program years 2019–2022
  1. Lexiscan Cardiology $5,525 5 payments
  2. Biograph Vision $717 10 payments
  3. LEXISCAN Hospital And Transplant $284 1 payment
  4. VYNDAMAX $101 1 payment
  5. SPECT Symiba Intevo $90 3 payments
  6. Lutathera Radioactive targeted therapy - Neuroendocrine tumors $44 1 payment
  7. Xofigo $40 2 payments
  8. LUTATHERA Oncology $33 2 payments
  9. Axumin $25 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$39,540

Medicare's payments for the services billed

Medicare patients

699

Average age 76

Services billed

708

308 women, 391 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 60%
Arthritis 56%
Heart failure 46%
Chronic kidney disease 41%
Diabetes 40%
Atrial fibrillation 39%
COPD 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

140 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nuclear Medicine in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record